Webinar – Managing a team and patients during a pandemic

ABSTRACT

This video interview is based on the slide deck “Telemedicine in Multiple Sclerosis” by Mona Alkhawajah and Carlo Pozzilli. Dr Alkhawajah brings out the key points. 

‘Telemedicine’ infers the use of digital technologies to deliver healthcare services to patients at a distance. While telemedicine was previously considered an interesting concept to save on time and resources, its importance was quickly seen with the COVID-19 pandemic, where the medical community was obliged to find ways to improve the quality and efficiency of healthcare service provision while minimising the risk of disease transmission.

In this presentation, Drs Mona Alkhawajah and Carlo Pozzilli cover all the important aspects of telemedicine. By looking back on the history of telemedicine, they project us forward to its potential role in the care of the multiple sclerosis (MS) patient. A thorough analysis is provided of new applications for telemedicine, issues that need to be considered when implementing this technology, what the challenges are, and how they can be overcome.

BIOGRAPHY

MONA ALKHAWAJAH
Dr. Mona Alkhawajah is currently a Consultant Neurologist at the Neurosciences Department of King Faisal Specialist Hospital and Research Center, Riyadh (KFSHRC-R), and is an Assistant Professor at Al Faisal University. . She has been the Program Director of the Neurology Residency Training Program at KFSHRC-R for almost 5 years.Dr. Mona Alkhawajah received her Medical Degree from King Saud University, Riyadh. She then pursued her residency training in Neurology at KFSHRC-R. After obtaining her Saudi Board in Neurology, she completed her Fellowship in Neuroimmunology at the University of British Columbia, in Vancouver, Canada. That was followed by another fellowship in Neuromuscular Diseases at Vancouver General Hospital.Dr. Alkhawajah is currently conducting several research projects in the field of MS. She has established the first Multiple Sclerosis support group in the Kingdom, the first meeting took place in June 2014. She is the organizer of the first (2015) and second (2017) walk for MS in Saudi Arabia, and is actively involved in educating the public about MS through conferences and media. 

ABSTRACT

MANAGEMENT DURING A PANDEMIC

Prof Celia Oreja-Guevara concluded the e-workshop with an interesting keynote about managing a team and your patients during a pandemic.

This workshop was made possible with the support of Merck.

BIOGRAPHY

CELIA OREJA-GUEVARA
Professor Celia Oreja-Guevara is Vice Chair of Neurology and Head of Multiple Sclerosis Center at the University Hospital San Carlos, Madrid and Professor of Neurology at the University Complutense, Madrid, Spain. After receiving her MD from the University Complutense, Madrid, Professor OrejaGuevara completed a PhD in neuroimmunology at the Max-Planck-Institute for Neurobiology, University of Munich, Munich (Germany). She then went on to complete a residency in the Department of Neurology at the University of Bochum, Bochum (Germany) and a postdoctoral fellowship in neuroimaging at the University Hospital San Raffaele, Milan (Italy). She has also held posts at the University of Düsseldorf (Germany),Hospital de Fuenlabrada and at the University Hospital La Paz, both in Madrid. Professor Oreja-Guevara’s research interests centre on clinical and neuroimaging correlations in MS and the use of optical coherence tomography. Neuromyelitis optica (NMO) is among her other therapy areas of interest, and Professor OrejaGuevara is actively involved in the evaluation of new drugs for the treatment of MS and NMO. As an investigator, she has participated in a number of MS clinical trials and currently heads the Neuroimaging Group of the Spanish Neurological Society, and she is a member of the Scientific Committee of the European Academy of Neurology. Currently, Professor Oreja-Guevara is an expert for the Spanish Medicines Agency and for the Scientific Advisory Group on Neurology of the European Medicines Agency